In today’s recent session, 0.51 million shares of the Citius Oncology Inc (NASDAQ:CTOR) have been traded, and its beta is -0.19. Most recently the company’s share price was $0.84, and it changed around $0.05 or 5.65% from the last close, which brings the market valuation of the company to $60.02M. CTOR at last check was trading at a discount to its 52-week high of $49.00, offering almost -5733.33% off that amount. The share price’s 52-week low was $0.55, which indicates that the recent value has risen by an impressive 34.52% since then. We note from Citius Oncology Inc’s average daily trading volume that its 10-day average is 0.13 million shares, with the 3-month average coming to 103.88K.

Citius Oncology Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended CTOR as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Citius Oncology Inc is expected to report earnings per share of 0 for the current quarter.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Instantly CTOR has been showing a green trend so far today with a performance of 5.65% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.9800 on recent trading dayincreased the stock’s daily price by 14.29%. The company’s shares are currently down -27.05% year-to-date, but still up 34.65% over the last five days. On the other hand, Citius Oncology Inc (NASDAQ:CTOR) is -29.50% down in the 30-day period. We can see from the shorts that 27881.0 shares have been sold at a short interest cover period of 0.54 day(s).

Citius Oncology Inc (CTOR) estimates and forecasts

Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 5.74M in revenue for the current quarter. 1 analysts expect Citius Oncology Inc to make 8.6M in revenue for the current ending quarter.

Citius Oncology Inc (NASDAQ:CTOR)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 95.08% of Citius Oncology Inc shares, and 0.89% of them are in the hands of institutional investors. The stock currently has a share float of 18.10%. The former held 12.65 shares worth $10816.0, making up 0.02% of all outstanding shares.